Protagenic TherapeuticsPTIX
13F holders, Q1 2025 (March 31)9holders
2new positions
2sold out
$0.20avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Protagenic Therapeutics Inc. (PTIX) in their 13F filings, unchanged from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were HRT Financial LP ($24K), Geode Capital Management, LLC ($15K) and Virtu Financial LLC ($11K).
- Company
- Protagenic Therapeutics Inc.
- CUSIP
- 74365N202
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 2 | $18K |
All 13F filers, Q4 2024 → Q1 2025: 223,675 shares bought and 35,828 shares sold, net +187,847 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| HRT Financial LP | 0.00% | New | 124,015 | $24K |
| Geode Capital Management, LLC | 0.00% | Add +78.6% | 77,296 | $15K |
| Virtu Financial LLC | 0.00% | Add +210.8% | 55,530 | $11K |
| Vanguard Group Inc. | 0.00% | No change | 33,166 | $6K |
| Two Sigma Securities, LLC | 0.00% | New | 27,968 | $5K |
| State Street Corp. | 0.00% | No change | 13,812 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.1% | 5,917 | $1K |
| Bank of America Corp. | 0.00% | Add +8.0% | 54 | $10 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PTIX's weight in each manager's 13F, not the share of Protagenic Therapeutics Inc. the manager owns.